Orange Book product · Generic (ANDA)
METHYLTESTOSTERONE
METHYLTESTOSTERONE
At a glance
Feb 18, 2022
Approved
Generic (ANDA)
Application
AB
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Feb 18, 2022
4 yr 5 mo ago
Today
Pharmaceutical detail
Active ingredient
METHYLTESTOSTERONE
Strength
10MG
Dosage form
CAPSULE
Route
ORAL
TE code
AB
Application
ANDA 215270
Product number
001
Marketing status
RX
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of METHYLTESTOSTERONE
- —METANDRENBrand (NDA)
NDA 003240 · NOVARTIS
- —ORETON METHYLBrand (NDA)
NDA 003158 · SCHERING
- 2015METHYLTESTOSTERONEGeneric (ANDA)
ANDA 204851 · IMPAX LABS INC
- 1983METHYLTESTOSTERONEGeneric (ANDA)
ANDA 087111 · LANNETT
- 1982VIRILONGeneric (ANDA)
ANDA 087750 · CHARTWELL
- 1982METHYLTESTOSTERONEGeneric (ANDA)
ANDA 087092 · LANNETT
- —METHYLTESTOSTERONEGeneric (ANDA)
ANDA 084967 · HEATHER
- —TESTREDGeneric (ANDA)
ANDA 083976 · BAUSCH
- —ANDROID 5Generic (ANDA)
ANDA 087222 · VALEANT PHARM INTL
- —ORETONGeneric (ANDA)
ANDA 080281 · SCHERING
- —METHYLTESTOSTERONEGeneric (ANDA)
ANDA 084287 · IMPAX LABS
- —METHYLTESTOSTERONEGeneric (ANDA)
ANDA 080256 · LILLY
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
